Decita Injection 50 MG – Benefits, Dosage, Side Effects & Global Supply

Decita Injection 50 MG contains Decitabine, a prescription oncology medicine used for the treatment of certain blood cancers, including acute myeloid leukemia (AML) in appropriate patients. It is administered by intravenous infusion under specialist medical supervision.

Decita Injection 50 MG – Overview

Active Ingredient: Decitabine

Strength: 50 MG

Form: Injectable / lyophilized powder

Route: Intravenous infusion

Category: Oncology / Hematology

Prescription: Required

Benefits & Uses

Decitabine is a hypomethylating agent that affects DNA methylation in abnormal blood cells. Depending on the approved indication, it may be used for:

Treatment of eligible AML patients

Management of certain myeloid malignancies

Patients who may not be suitable for intensive chemotherapy

Specialist hospital-based oncology treatment

Decita Injection 50 MG Dosage

The dosage is individualized by the treating oncologist according to the patient's condition, body-surface area, blood counts and treatment response.

A commonly used regimen is 20 mg/m² by intravenous infusion once daily for 5 consecutive days, with treatment cycles repeated according to the prescribed protocol.

Another approved regimen uses 15 mg/m² every 8 hours for 3 consecutive days.

The 50 MG vial does not mean that 50 MG is necessarily administered as a single patient dose. Treatment must follow the prescribing information and specialist instructions.

Side Effects

Common side effects may include:

Neutropenia

Thrombocytopenia

Anemia

Fever

Fatigue

Nausea and vomiting

Diarrhea or constipation

Headache

Cough and infections

Decitabine can cause significant myelosuppression, increasing the risk of infection and bleeding. Regular blood-count monitoring is therefore important.

Important Precautions

Patients receiving Decita Injection may require monitoring of:

Complete blood counts

Platelets

Liver and kidney function

Signs of infection

Bleeding or bruising

Treatment response

Pregnancy and breastfeeding considerations should be discussed with the treating healthcare professional.

Decita Injection 50 MG Supply in USA, UK, UAE & South Africa

Cordium Pharmaceuticals Pvt Ltd supports pharmaceutical export and international supply for authorized healthcare buyers.

USA: Supply for eligible hospitals, healthcare organizations and authorized pharmaceutical buyers, subject to U.S. requirements.

UK: Pharmaceutical supply for authorized healthcare procurement and distributors, subject to UK regulations.

UAE: Supply to authorized hospitals, distributors and importers subject to UAE pharmaceutical requirements.

South Africa: Supply for authorized healthcare organizations and pharmaceutical distributors subject to local regulations.

Why Choose Cordium Pharmaceuticals Pvt Ltd?

India-based pharmaceutical exporter

International pharmaceutical supply support

Hospital and distributor procurement

Competitive quotations

Export documentation assistance

Professional packaging and shipping coordination

Support for international markets

FAQs

What is Decita Injection 50 MG?

Decita Injection 50 MG contains Decitabine, an anticancer medicine used for certain hematological malignancies.

What is Decita Injection used for?

It is used for specific blood cancers, including AML in eligible patients, according to the applicable approved indication.

How is Decita Injection administered?

It is administered through intravenous infusion by qualified healthcare professionals.

What are the major side effects?

Low blood-cell counts, fever, fatigue, nausea, vomiting and infections are among the possible adverse effects.

Is Decita Injection prescription-only?

Yes. It should only be used under the supervision of a qualified healthcare professional.

Can Cordium Pharmaceuticals supply Decita Injection internationally?

Cordium Pharmaceuticals Pvt Ltd supports international pharmaceutical supply for authorized buyers, subject to product availability and destination-country regulations.

Medical Disclaimer: Decita Injection 50 MG is a prescription oncology medicine. This content is for general educational information and does not replace advice from a qualified healthcare professional. Dosage and treatment must be determined by the treating specialist.